These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2574111)

  • 1. Plasma protein binding of alpidem in healthy volunteers, in neonates and in liver or renal insufficiency.
    Pacifici GM; Bianchetti G; Viani A; Rizzo G; Carrai M; Allen J; Morselli PL
    Eur J Clin Pharmacol; 1989; 37(1):29-32. PubMed ID: 2574111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma protein binding of zolpidem in liver and renal insufficiency.
    Pacifici GM; Viani A; Rizzo G; Carrai M; Ganansia J; Bianchetti G; Morselli PL
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):439-43. PubMed ID: 3198298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding of clonazepam in hepatic and renal insufficiency and after hemodialysis.
    Pacifici GM; Viani A; Rizzo G; Carrai M; Rane A
    Ther Drug Monit; 1987 Dec; 9(4):369-73. PubMed ID: 3424402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein binding of ethinyloestradiol: effect of disease and interaction with drugs.
    Pacifici GM; Viani A; Rizzo G; Carrai M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):362-5. PubMed ID: 2777426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics and tolerability of alpidem in healthy subjects given increasing single doses.
    Jonkman JH; Bianchetti G; Grasmeijer G; Oosterhuis B; Thiercelin JF; Thénot JP; Guillet P; Morselli PL
    Eur J Clin Pharmacol; 1991; 41(4):369-74. PubMed ID: 1687121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein binding of etomidate in patients with renal failure or hepatic cirrhosis.
    Carlos R; Calvo R; Erill S
    Clin Pharmacokinet; 1979; 4(2):144-8. PubMed ID: 455872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein binding of thiopental in patients with impaired renal or hepatic function.
    Ghoneim MM; Pandya H
    Anesthesiology; 1975 May; 42(5):545-9. PubMed ID: 1130720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis.
    Costela JL; Jiménez R; Calvo R; Suárez E; Carlos R
    Acta Anaesthesiol Scand; 1996 Jul; 40(6):741-5. PubMed ID: 8836272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of alpidem and its metabolites in human plasma by high-performance liquid chromatography and fluorimetric detection.
    Ascalone V; Catalani P; Dal Bo' L; Deschamps N; Guinebault P
    J Chromatogr; 1987 Feb; 414(1):101-8. PubMed ID: 2883194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and safety of single intravenous infusions of the adenosine agonist, AMP 579, in patients with end-stage renal insufficiency.
    Zannikos PN; Jensen BK; Boutouyrie BX; Tripp L; Yongyi L; McGowan T; Waldman SA; Greenberg HE
    J Clin Pharmacol; 2000 Jul; 40(7):745-51. PubMed ID: 10883416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma protein binding of azapropazone in patients with kidney and liver disease.
    Jähnchen E; Blanck KJ; Breuing KH; Gilfrich HJ; Meinertz T; Trenk D
    Br J Clin Pharmacol; 1981 Apr; 11(4):361-7. PubMed ID: 7259929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma protein binding of dicloxacillin: effects of age and diseases.
    Pacifici GM; Viani A; Taddeucci-Brunelli G; Rizzo G; Carrai M
    Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):622-6. PubMed ID: 3429065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.
    Viani A; Rizzo G; Carrai M; Pacifici GM
    Br J Clin Pharmacol; 1992 Mar; 33(3):299-304. PubMed ID: 1576051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum binding of ketoconazole in health and disease.
    Martínez-Jordá R; Rodriguez-Sasiain JM; Suárez E; Calvo R
    Int J Clin Pharmacol Res; 1990; 10(5):271-6. PubMed ID: 2079384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of development, aging, and renal and hepatic insufficiency as well as hemodialysis on the plasma concentrations of albumin and alpha 1-acid glycoprotein: implications for binding of drugs.
    Pacifici GM; Viani A; Taddeucci-Brunelli G; Rizzo G; Carrai M; Schulz HU
    Ther Drug Monit; 1986; 8(3):259-63. PubMed ID: 3750366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of serum protein binding of felodipine.
    Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood binding of selezen (imidazole salicylate) in man.
    Zini R; Morin D; Acuto GC; Bianchini C; de Santis F; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):242-9. PubMed ID: 1869346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical studies with the new anxiolytic alpidem in anxious patients: an overview of the European experiences.
    Musch B; Morselli PL; Priore P
    Pharmacol Biochem Behav; 1988 Apr; 29(4):803-6. PubMed ID: 2901120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of alpidem, an imidazopyridine anxiolytic, and its metabolites by column-switching high-performance liquid chromatography with fluorescence detection.
    Flaminio L; Ripamonti M; Ascalone V
    J Chromatogr A; 1994 May; 668(2):403-11. PubMed ID: 7913366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.